ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 1300

$489K Total Retail Price of All Prescriptions

Rank: 34 out of 1300

365 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

12% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 3,528 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 427 194 1 1
LISINOPRIL 272 162 2 2
METFORMIN HCL 194 97 3 7
HYDROCODONE-ACETAMINOPHEN 184 123 S3 4 5
OMEPRAZOLE 174 96 5 4
HYDROCHLOROTHIAZIDE 145 97 6 10
RISPERIDONE 141 60 7 77
RANITIDINE HCL 137 49 8 27
OLANZAPINE 134 41 9 86
SIMVASTATIN 125 55 10 3
DIVALPROEX SODIUM 122 33 11 62
IBUPROFEN 110 51 12 72
BUSPIRONE HCL 110 0 12 166
AMLODIPINE BESYLATE 97 97 14 6
CETIRIZINE HCL 96 21 15 276
FUROSEMIDE 92 63 16 8
GABAPENTIN 90 37 17 15
POLYETHYLENE GLYCOL 3350 85 56 18 65
FLUOXETINE HCL 80 42 19 31
NEXIUM 77 36 20 46
QUETIAPINE FUMARATE 75 0 21 57
PROPRANOLOL HCL 74 0 22 116
ATENOLOL 73 57 23 12
POTASSIUM CHLORIDE 73 47 23 18
CARBAMAZEPINE 73 0 23 125
BENZTROPINE MESYLATE 71 22 R 26 178
ALENDRONATE SODIUM 71 47 26 20
OXCARBAZEPINE 70 0 28 227
TAMSULOSIN HCL 68 29 29 25
LITHIUM CARBONATE 67 0 30 168
CRESTOR 64 29 31 39
VYTORIN 63 44 32 194
AZITHROMYCIN 62 46 33 79
FAMOTIDINE 60 25 34 73
LEVETIRACETAM 59 12 35 107
PRAVASTATIN SODIUM 57 39 36 23
DILANTIN 56 48 37 321
ABILIFY 56 0 37 129
TOPIRAMATE 54 0 39 158
SPIRIVA 53 32 40 45
LOVASTATIN 52 25 41 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.